Quality-Adjusted Survival with Ribociclib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with HR±HER2− Advanced Breast Cancer in the MONALEESA-3 Trial
Titel:
Quality-Adjusted Survival with Ribociclib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with HR±HER2− Advanced Breast Cancer in the MONALEESA-3 Trial
Auteur:
Jerusalem, Guy Delea, Thomas E. Martin, Migule De Laurentiis, Michelino Nusch, Arnd Beck, J. Thaddeus Chan, Arlene Im, Seock-Ah Neven, Patrick Lonshteyn, Alexander Chandiwana, David Lanoue, Brad Fasching, Peter A.